Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 469))

Abstract

The lipid phosphoric acids, including lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are generated from membranes of many different types of stimulated cells. In extracellular fluids, these distinctive phospholipids are potent mediators of growth and many other cellular functions,1,2 and intracellularly serve as messengers of diverse signals from cell-surface receptors.3 Both lipid phosphoric acid mediators are characterized by widespread cellular production, often separate synthetic pathways for the intracellular and secreted pools, micromolar maximal concentrations in serum and some other fluids, high levels of binding to albumin and some other serum proteins, and biodegradation by one or more specific enzymatic mechanisms. The multicomponent pathway for biosynthesis of secreted LPA is distinct from those which produce LPA in cellular metabolism, and is one well-described example of the compartmental generation of lipid phosphoric acids. Efficient generation of LPA for secretion requires sequential release of plasma membrane vesicles from stimulated leukocytes, platelets or other cells, exposure of the vesicles to sphingomyelinase, production of phosphatidic acid (PA) by phospholipase (PL) C- and/or D-dependent mechanisms, and conversion of PA to LPA by a secretory PLA2.4 LPA is enzymatically inactivated by lysophospholipases, acetyltransferases and phosphatidate phosphohydrolases of differing specificities, whereas SIP is cleaved predominantly by a lyase.2,5 The steady-state tissue and fluid levels of LPA and SIP are determined by the ratio of enzymatic activities of the biosynthetic and degradative systems. LPA has many potent effects on cellular proliferation and differentiation, cellular migration, platelet shape change and aggregation, smooth muscle tone, and activities of membrane ion channels and enzymes.1 The broad range of effects of S1P is similar to that of LPA, but S1P is a more prominent mediator of endothelial cell adherence and junction formation, and neurite retraction.2 Early results of studies of lipid phosphoric acids in cell death suggest that S1P and LPA may be active inhibitors of apoptosis. The capacity to suppress formation of intracellular S1P with selective inhibitors of sphingosine kinase has facilitated investigations of its possible role as an intracellular messenger,3 whereas any similar functions of LPA and PA are less clear. The different contributions of S1P exhibit cellular specificity. Intracellular signaling functions of S1P are best appreciated in fibroblasts and mast cells, and extracellular mediator activities predominate in platelets, neurons, cardiac myocytes and macrophages.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Refferences

  1. W.H. Moolenaar. Lysophosphatidic acid, a multifunctional phospholipid messenger, J. Biol. Chem.270(22):12949(1995).

    PubMed  CAS  Google Scholar 

  2. S. Spiegel and S. Milstein. Sphingolipid metabolites: members of a new class of lipid second messengers, J. Membrane Biol.146:225 (1995).

    Article  CAS  Google Scholar 

  3. A. Olivera and S. Spiegel. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens, Nature365:557 (1993).

    Article  PubMed  CAS  Google Scholar 

  4. O. Fourcade, M-F. Simon, C. Viode, N. Rugani, F. Leballe, A. Ragab, B. Fournie, L. Sarda, and H. Chap. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells, Cell.80:919 (1995).

    Article  PubMed  CAS  Google Scholar 

  5. A. Wang, R.A. Deems, and E.A. Dennis. Cloning, expression, and catalytic mechanism of murine lysophospholipase I, J. Biol. Chem.272(19):12723 (1997).

    Article  PubMed  CAS  Google Scholar 

  6. J. H. Hecht, J.A. Weiner, S.R. Post, and J. Chun. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex, J. Cell Biol.135(4):1071 (1996).

    Article  PubMed  CAS  Google Scholar 

  7. S. An, M.A. Dickens, T. Bleu, O.G. Hallmark, and E.J. Goetzl. Molecular cloning of the human edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid, Biochem. and Biophys. Res. Comm.231(3):619 (1997).

    Article  CAS  Google Scholar 

  8. R. Treisman. Journey to the surface of the cell: Fos regulation and the SRE, The EMBO Journal.14(20):4905 (1995).

    PubMed  CAS  Google Scholar 

  9. S. An, T. Bleu, W. Huang, O.G. Hallmark, S.R. Coughlin, E.J. Goetzl. Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids, FEBS Letters417:279 (1997).

    Article  PubMed  CAS  Google Scholar 

  10. S. An, T. Bleu, O.G. Hallmark, and E.J. Goetzl. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid, J. Biol Chem.,in press

    Google Scholar 

  11. M.E. Abood, K.E. Ditto, M.A. Noel, V.M. Showalter, and Q. Tao. Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with tose of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells, Biochem. Pharmacol.53:207 (1997).

    Article  PubMed  CAS  Google Scholar 

  12. N. Stella, P. Schweitzer, and D. Piomelli. A second endogenous cannabinoid that modulates long-term potentiation, Nature388:773 (1997).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goetzl, E.J., An, S. (1999). A Subfamily of G Protein-Coupled Cellular Receptors for Lysophospholipids and Lysosphingolipids. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4793-8_38

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7171-7

  • Online ISBN: 978-1-4615-4793-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics